AACE 2018

In part 1 of this Exclusive Interview, Joshua Safer talks with Diabetes in Control Publisher Steve Freed about the need to understand the evidence for and approach to transgender medicine, and strategies for the use of hormones.

In part 2 of this Exclusive Interview, Joshua Safer talks with Diabetes in Control Publisher Steve Freed about working with transgender patients and the course of a conversation with a new patient.

In part 3 of this Exclusive Interview, Joshua Safer talks with Diabetes in Control Publisher Steve Freed about the number of specialists that can be found and more on the field overall as a specialty.

In part 4 of this Exclusive Interview, Joshua Safer talks with Diabetes in Control Publisher Steve Freed about the potential of hormones to cause diabetes.

Richard Bergenstal, MD is an endocrinologist in Minneapolis, Minnesota and is affiliated with Park Nicollet Methodist Hospital. He received his medical degree from University of Chicago Pritzker School of Medicine and has been in practice for more than 20 years. Dr. Bergenstal accepts several types of health insurance, listed below. He is one of 5 doctors at Park Nicollet Methodist Hospital who specialize in Endocrinology, Diabetes & Metabolism.

In this Exclusive Interview transcript, Richard Bergenstal talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston about emerging automated insulin delivery devices and a dual pathway approach for CGMS and medications.

In this Exclusive Interview, Richard Bergenstal talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston about emerging automated insulin delivery devices.

In part 1 of this Exclusive Interview, Richard Bergenstal talks with Diabetes in Control Publisher Steve Freed about emerging automated insulin delivery devices and the impact of CGM use on blood sugar management.

In part 2 of this Exclusive Interview, Richard Bergenstal talks with Diabetes in Control Publisher Steve Freed about the educational benefit from using CGM for type 2 diabetes.

In part 3 of this Exclusive Interview, Richard Bergenstal talks with Diabetes in Control Publisher Steve Freed about the promising innovations and studies being shared with diabetes professionals.